Searched for
BEST PHARMA FUNDS
How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...- Rising global bond yields, FCNR-B inflows and SEBI's CAS to shape market dynamics: HDFC Securities CEO Dhiraj RelliIndia is grappling with rising global bond yields and surging oil prices, which are heightening imported inflation. These economic challeng...
- Best gilt mutual funds to invest in August 2026Gilt funds are not recommended to regular debt investors because they are risky and volatile. Gilt funds suffer the most when the rates go ...
- Magnum SIF by SBI Mutual Fund garners over Rs 1,100 crore in Equity Ex-Top 100 Long Short Fund NFOSBI Mutual Fund’s Magnum Equity Ex-Top 100 Long Short Fund mobilised Rs 1,154 crore, the highest NFO collection in the Equity SIF category,...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Time to increase the risk quotient? Maybe, but selectively: 5 largecaps from different sectors with upside potential of up to 30%When a market starts rising and buying makes a comeback, something happens to a large majority of investors. They get restless. The safe, m...
- ETMarkets NRI Talk | Alternatives can account for up to 20% of an NRI's India allocation: Shiv GuptaFrom portfolio management services (PMS) and alternative investment funds (AIFs) to private credit, these asset classes offer the potential...
- 9 microcap multibaggers: How India's stock market minnows beat every major index in six monthsIndia's smallest listed stocks delivered the strongest market run in six months. The Nifty Microcap 250 index rose eleven percent, beating ...
- Sankaran Naren favours banks, power as oil risks loomSankaran Naren, CIO of ICICI Prudential Asset Management, remains bullish on banks, power utilities, oil refiners and pharmaceuticals, citi...
- Nifty correction a buying opportunity, but keep 10-15% cash: Sonam SrivastavaBanking is still the best risk-reward pocket in my view—valuations are attractive, credit growth is strong, and NPAs are very low. There’s ...
- Best corporate bond mutual funds to invest in July 2026Corporate bond funds offer relatively safe debt investment options for near-term goals. These schemes invest in highly-rated company papers...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- Will Sensex, Nifty extend gains on Monday? Q1 earnings, global tech selloff among 6 factors to steer D-St this weekDalal Street ended the week on a strong note, with the Sensex and Nifty gaining over 1% on Friday. Investors will track six key market trig...
- For investors with high risk-appetite: 5 mid-cap stocks from different sectors with upside potential of up to 21%Brace for trouble. The US-Iran conflict now appears to be gaining in intensity and the commodities market is taking the current spiral of v...
- Stocks, gold and debt: Why ICICI Pru’s Dharmesh Kakkad favours a multi-asset strategy nowICICI Prudential's Dharmesh Kakkad advises investors against chasing the best-performing asset classes, arguing that a dynamic multi-asset ...
- Korea's pain will be India's gain? Why Nifty bears betting on Kospi crash may get disappointedForeign investors pulled ₹1.92 lakh crore from India in 2026 to chase the East Asian AI chip boom. As South Korea's KOSPI experiences wild ...
- For investors with 1- to 2-year perspective: Strong balance sheet and growth path; 5 large-caps with upside potential up to 33%With Israel refusing to play ball in the so-called US-Iran ceasefire, it was expected that things might remain fragile with regards to the ...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Missed the FII U-turn? 6 stocks turned multibagger after foreign investors corrected their mistakeForeign institutional investors (FIIs) reversed their selling trend in six select Indian stocks, turning them into multibaggers. Bajaj Cons...
Load More
